We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+2.11%
1 Year Est. Return
+158.98%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$1.36M
Cap. Flow
+$6.26M
Cap. Flow %
5.25%
Top 10 Hldgs %
39.35%
Holding
221
New
78
Increased
37
Reduced
38
Closed
48

Top Buys

1
IBIT icon
iShares Bitcoin Trust
IBIT
+$7.97M
2
CNC icon
Centene
CNC
+$7.51M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.8M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.61M
5
LLY icon
Eli Lilly
LLY
+$2.51M

Top Sells

1
HUM icon
Humana
HUM
+$9.46M
2
DVA icon
DaVita
DVA
+$5.09M
3
WBA
Walgreens Boots Alliance
WBA
+$3.51M
4
CAH icon
Cardinal Health
CAH
+$2.43M
5
DFS
Discover Financial Services
DFS
+$1.87M

Sector Composition

1 Healthcare 60.53%
2 Financials 20.86%
3 Materials 3.73%
4 Energy 1.78%
5 Industrials 0.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FCNCA icon
51
First Citizens BancShares
FCNCA
$24.6B
$667K 0.56%
360
-634
-64% -$1.29M
IMCR icon
52
Immunocore
IMCR
$1.78B
$663K 0.56%
+22,330
New +$670K
AMGN icon
53
CALL
Amgen
AMGN
$198B
$618K 0.52%
+239
New +$70.6K
SWTX
54
DELISTED
SpringWorks Therapeutics
SWTX
$610K 0.51%
+13,819
New +$636K
RYTM icon
55
Rhythm Pharmaceuticals
RYTM
$7.31B
$609K 0.51%
11,501
-6,811
-37% -$378K
VKTX icon
56
Viking Therapeutics
VKTX
$4.31B
$579K 0.49%
+23,970
New +$758K
CNTA
57
DELISTED
Centessa Pharmaceuticals
CNTA
$542K 0.46%
37,720
+19
+0.1% +$311
COGT icon
58
Cogent Biosciences
COGT
$6.68B
$540K 0.45%
90,211
+22,594
+33% +$177K
EQX icon
59
Equinox Gold
EQX
$6.8B
$523K 0.44%
76,032
+18,960
+33% +$122K
VRDN icon
60
Viridian Therapeutics
VRDN
$1.99B
$502K 0.42%
37,211
+11,974
+47% +$204K
GDRX icon
61
GoodRx Holdings
GDRX
$1.06B
$449K 0.38%
+101,755
New +$478K
AA icon
62
Alcoa
AA
$11.6B
$440K 0.37%
+14,432
New +$505K
SRRK icon
63
Scholar Rock
SRRK
$6.33B
$421K 0.35%
13,103
– –
SMBK icon
64
SmartFinancial
SMBK
$823M
$419K 0.35%
13,479
-1,433
-10% -$47.6K
CORT icon
65
CALL
Corcept Therapeutics
CORT
$9.72B
$414K 0.35%
+92
New +$5.6K
NVO
66
Novo Nordisk
NVO
$223B
$407K 0.34%
+5,859
New +$484K
FHN icon
67
First Horizon
FHN
$12.2B
$407K 0.34%
20,934
-22,558
-52% -$464K
HOOD icon
68
Robinhood
HOOD
$89.7B
$400K 0.34%
9,619
-10,696
-53% -$509K
KALV
69
DELISTED
KalVista Pharmaceuticals
KALV
$393K 0.33%
34,098
-7,854
-19% -$80.2K
ETNB
70
DELISTED
89bio
ETNB
$387K 0.32%
53,224
+26,382
+98% +$231K
KROS icon
71
PUT
Keros Therapeutics
KROS
$211M
$381K 0.32%
153
– –
APGE icon
72
Apogee Therapeutics
APGE
$10.1B
$343K 0.29%
9,178
-8,762
-49% -$339K
MYFW icon
73
First Western Financial
MYFW
$323M
$342K 0.29%
17,384
+2,846
+20% +$55.8K
INDB icon
74
Independent Bank
INDB
$4.08B
$337K 0.28%
+5,382
New +$354K
SAGE
75
DELISTED
Sage Therapeutics
SAGE
$336K 0.28%
42,216
-11,505
-21% -$84.2K
1 2
3
4 5

Similar funds

VC
VarCov Co Darien, Connecticut $268M AUM
AL
AIP LLC New York $268M AUM 40.4% 1-Year Est. Return
FC
Foursixthree Capital New York $268M AUM 115.24% 1-Year Est. Return
NF
Nvest Financial Portsmouth, New Hampshire $268M AUM 22.87% 1-Year Est. Return
PF
Prosperitas Financial Valencia, California $268M AUM 32.64% 1-Year Est. Return
UI
Untitled Investments New York $269M AUM 11.35% 1-Year Est. Return
SSWM
Strait & Sound Wealth Management San Francisco, California $269M AUM 22.03% 1-Year Est. Return
AC
Applied Capital Little Rock, Arkansas $268M AUM 16.92% 1-Year Est. Return

Persistent Asset Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Persistent Asset Partners held 221 positions worth $119M, down 1.1% from $121M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Persistent Asset Partners deployed $6.26M of net new capital in Q1 2025, opening 78 new positions and adding to 37 existing holdings. Its largest new stake was iShares Bitcoin Trust: 150,623 shares worth $7.05M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 68% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Humana, an estimated $9.46M trimmed.

  • Persistent Asset Partners's largest Q1 2025 buy was iShares Bitcoin Trust: 150,623 shares worth $7.05M.
  • Persistent Asset Partners added most to Centene in Q1 2025, an estimated $7.51M increase.
  • Persistent Asset Partners's biggest Q1 2025 reduction was Humana, cutting an estimated $9.46M.
  • Persistent Asset Partners fully exited Walgreens Boots Alliance in Q1 2025, selling an estimated $3.51M.
  • Persistent Asset Partners's ten largest holdings make up 39% of its $119M portfolio in Q1 2025.
  • Persistent Asset Partners opened 78 new positions and closed 48 in Q1 2025.
  • Persistent Asset Partners's portfolio value fell 1.1% quarter-over-quarter to $119M.

Based on Persistent Asset Partners's 13F filing for Q1 2025, filed 13 May 2025.